Auricular point stimulation plus dexamethasone trials for Nausea and Vomiting Caused by Chemotherapy

All Auricular point stimulation plus dexamethasone trials · All Nausea and Vomiting Caused by Chemotherapy trials

Phase breakdown

Recruiting trials studying Auricular point stimulation plus dexamethasone for Nausea and Vomiting Caused by Chemotherapy

• Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
  NCT07716176 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
  NCT07716228 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
  NCT07537699 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
  NCT07537660 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Auricular point stimulation plus dexamethasone for Nausea and Vomiting Caused by Chemotherapy?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.